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In Central America, the traditional temazcales or wood-
fired steam baths, commonly used by many Native American 
populations, are often heated by wood fires with little ven-
tilation, and this use results in high wood smoke exposure. 
Urinary mutagenicity has been previously employed as a 
non-invasive biomarker of human exposure to combustion 
emissions. This study examined the urinary mutagenic-
ity in 19 indigenous Mayan families from the highlands of 
Guatemala who regularly use temazcales (N = 32), as well as 
control (unexposed) individuals from the same population 
(N = 9). Urine samples collected before and after temazcal 
exposure were enzymatically deconjugated and extracted 
using solid-phase extraction. The creatinine-adjusted muta-
genic potency of urine extracts was assessed using the plate-
incorporation version of the Salmonella mutagenicity assay 
with strain YG1041 in the presence of exogenous metabolic 
activation. The post-exposure mutagenic potency of urine 
extracts were, on average, 1.7-fold higher than pre-exposure 
samples (P < 0.005) and also significantly more mutagenic 
than the control samples (P < 0.05). Exhaled carbon mon-
oxide (CO) was ~10 times higher following temazcal use 
(P < 0.0001), and both CO level and time spent in temazcal 
were positively associated with urinary mutagenic potency 
(i.e. P < 0.0001 and P = 0.01, respectively). Thus, the wood 
smoke exposure associated with temazcal use contributes 
to increased excretion of conjugated mutagenic metabo-
lites. Moreover, urinary mutagenic potency is correlated 
with other metrics of exposure (i.e. exhaled CO, duration of 
exposure). Since urinary mutagenicity is a biomarker asso-
ciated with genetic damage, temazcal use may therefore be 
expected to contribute to an increased risk of DNA damage 
and mutation, effects associated with the initiation of cancer.
Introduction
Wood smoke and wood smoke extract, which contain a 
complex mixture of substances including polycyclic aromatic 
hydrocarbons (PAHs), formaldehyde and respirable particulate 
matter (1), are mutagenic and genotoxic in bacterial and 
mammalian cells (2–9), carcinogenic in experimental animals 
(10,11) and, in epidemiologic studies, positively associated 
with increased human lung cancer incidence (12). Indoor air 
containing emissions from the combustion of biomass fuel 
(primarily wood) has been classified by the International 
Agency for Research on Cancer as a Group  2A carcinogen 
(i.e. probably carcinogenic to humans) (1). Exposure to the 
particulate portion of combustion emissions has also been 
associated with adverse health effects such as pulmonary injury, 
upper respiratory tract infection, asthma, chronic obstructive 
pulmonary disease, low birth-weight and infant mortality (for a 
review, see Naeher et al. (13)).
Existing monitoring methods for wood smoke exposure 
assessment include personal exposure devices for particulate 
matter, monitoring of exhaled or blood carbon monoxide (CO) 
levels and monitoring of urinary concentrations of various 
components of wood smoke such as PAHs (or their metabo-
lites), potassium, methoxyphenols and levoglucosan (for a 
review see Simpson and Naeher) (14). Urinary methoxyphe-
nol concentration was assessed in individuals from the same 
study population as that examined in the current work, compar-
ing levels between individuals who use open fires for cooking 
versus vented wood stoves (i.e. planchas) (15). Urinary meth-
oxyphenol levels were significantly increased in the individuals 
using open fires, relative to those that used planchas, indicat-
ing that this biomarker is effective for quantifying exposures 
to inhaled wood smoke. However, biomarkers such as urinary 
methoxyphenols and levoglucosan require a priori knowledge 
of components in wood smoke, as well as reliable information 
on metabolism and urinary excretion. Although promising, 
since levoglucosan is solely produced by the combustion of 
cellulose, which is a major component of biomass combustion 
emissions (16,17), urinary levoglucosan levels are also affected 
by dietary consumption of smoked or grilled meats and cara-
melized sugars (18). Additionally, from a genetic toxicology 
perspective, individual chemical biomarkers cannot provide an 
integrated appraisal of total exposure to agents capable of caus-
ing genetic damage, an effect related to the initiation of tumour 
formation. It has recently been recognized that new methods 
for biological monitoring of wood smoke exposure are required 
in order to fill knowledge gaps relating to determination of (i) 
safe exposure levels and (ii) regulatory options for control of 
biomass combustion emissions (13,14,19). An ideal biomarker 
would be specific to wood smoke and/or biomass combustion 
emissions, be non-invasive, be able to suitably account for vari-
ations in exposure magnitude and differences in individual sus-
ceptibility and not require a priori knowledge of wood smoke 
composition (should that information not be available).
Urinary excretion of mutagens, as detected using the 
Ames/Salmonella reverse mutation assay, has previously been 
shown to be a useful biomarker of human exposure to com-
bustion emissions, including wood smoke (20–23) and polluted 
ambient air (24,25). Kato et al. (21) examined urinary mutagen-
icity levels in employees of a charcoal plant and demonstrated 
that urinary mutagenicity was associated with wood smoke 
exposure level (estimated based on task), as well as genetic 
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damage (i.e. DNA adducts in urothelial cells). Assessment of 
urinary mutagenic activity is non-invasive, does not require 
a priori knowledge about the components of wood/biomass 
smoke, and can be effectively used to investigate interindivid-
ual variability. Although extrapolations from urinary mutagen-
icity to risk of adverse effect are tenuous, this biomarker has 
thus far been shown to be effective for quantitative assessment 
of occupational and/or environmental exposures to mutagenic 
combustion emissions.
A particular form of the traditional temazcal (i.e. wood-fired 
steam baths) used by Native American groups are routinely used 
by indigenous populations in Central America, including an 
estimated 1–2 million indigenous Mayan people in the western 
highlands of Guatemala (26). The temazcales used by these popu-
lations are typically small (~5.5 m3), minimally ventilated rooms 
(<0.5 air changes per hour) that are heated by burning a wood fire 
inside the structure to warm volcanic rocks (26) (Figure 1). Users 
enter the temazcal once the fire has reduced to smoke-emitting 
embers, which are traditionally left inside the structure during 
use. A recent survey of 97 households in the western highlands 
of Guatemala showed that >90% of respondents use the temaz-
cal once or twice per week, and 4% use it as frequently as three 
times per week, typically for hygienic or ceremonial purposes 
(26). Only 4% of surveyed individuals indicated that they use the 
temazcal less than twice per month. A second study of the same 
population found that the average CO concentration in the temaz-
cal during use was 661 ± 62 ppm, with a range from <7 ppm to 
>1980 ppm (27). Average exhaled (alveolar) CO levels in adults 
following temazcal was 61 ppm, and ranged from 3 to 230 ppm 
(26). These environmental and biological concentrations are high 
enough to pose a risk of acute effects from CO poisoning.
This study evaluated urinary mutagenicity in adults and 
children of Mayan families from the same highland area in 
Guatemala as that examined in the aforementioned studies 
(26,27). The population of temazcal users constitutes a well-
defined group of individuals exposed to emissions from wood 
combustion, and the study employed urinary mutagenicity to 
evaluate exposures to mutagenic combustion emissions associ-
ated with temazcal use.
Materials and methods
Study population identification and sample collection
Study subjects were 41 individuals from 20 Mam-speaking indigenous Mayan 
families from the western highlands of Guatemala. The study population 
included 17 children (ages 2–15), 15 adult females (ages 16–53) and 9 adult 
males (ages 18–69; Table I). The study included both exposed subjects, who 
regularly use traditional temazcales (N  =  32), as well as control individuals 
from the same population who do not use temazcales (N  =  9; Table I). All 
participants were healthy at the time of enrolment. Study subjects completed 
a questionnaire that captured information on demographics and exposure fre-
quency. Usually, families use temazcales before going to bed at night. All study 
subjects were non-smokers. Urine samples were collected in the morning (i.e. 
first morning void) the day of temazcal use (i.e. pre-exposure sample), as well 
as in the morning the day following temazcal exposure (i.e. post-exposure sam-
ple). For each exposure, the amount of time spent in the temazcal was recorded 
by the head of the household. Control urine samples were collected from sub-
jects in the same population. Urine volume was measured and recorded by field 
staff, and the samples were subsequently aliquoted, individually barcoded to 
ensure confidentiality and objective analyses and frozen at −80°C until analy-
sis. All aspects of this study conform to standards and practices outlined in 
the protocol approved by the Research Ethics Board of Health Canada and the 
Committee for Protection of Human Subjects at the University of California, 
Berkeley. Informed consent and assent forms were signed by study participants 
prior to sample collection.
Exhaled CO analysis
Exhaled CO levels (expressed as ppm) were measured both pre- and post-
exposure (i.e. immediately before and after temazcal use), as described in (27). 
Briefly, a MicroCO electrochemical breath monitor (MicroDirect, Lewiston, 
ME, USA) was employed to measure CO concentrations in exhaled breath. 
Study subjects first held their breath for 20 s, and then exhaled continuously 
and completely. Three replicate measurements were taken per individual, with 
1–2 min between attempts. The average of three successful attempts is reported. 
MicroCO breath monitors were calibrated using a laboratory standard each 
week during the study period.
Hydrolysis and extraction of urine samples
Coded urine samples (~50 ml) were thawed and filtered to remove urothe-
lial cells. The exact volume of each sample was recorded, and the samples 
enzymatically deconjugated in 0.2 M (10% v/v) sodium acetate buffer 
(pH 5.0) (Sigma–Aldrich Canada, Oakville, Ontario, Canada), containing 
β-glucuronidase (6 units/ml urine; Sigma–Aldrich Canada) and sulphatase (2 
units/ml urine; Sigma–Aldrich Canada) for 16 h at 37°C. Deconjugated urinary 
metabolites were then concentrated using solid-phase extraction on C18 silica 
(Avantor Performance Materials, Center Valley, PA, USA) with methanol elu-
tion (EMD Chemicals, Billerica, MA, USA) as described previously (21,28). 
The resulting extracts were reconstituted in dimethylsulphoxide (DMSO; 
Sigma–Aldrich Canada) to produce urine extracts suitable for mutagenicity 
assessment. Extracts were stored at 4°C until use.
Mutagenicity assessment of urine extracts
The mutagenic activity of urine extracts was assessed using the standard plate-
incorporation version of the Ames/Salmonella reverse mutation assay with 
Salmonella strain YG1041(obtained from Dr Takehiko Nohmi) and Aroclor-
induced rat liver S9 (i.e. S9, Molecular Toxicology Inc., Boone, NC), as 
described in Mortelmans and Zeiger (29). These conditions were selected based 
on the results published by Kato et al. (21), which showed that the combination 
of strain YG1041, a metabolically enhanced version of the frameshift-detecting 
Fig. 1. The interior of a traditional temazcal used by the study population. 
From Thompson et al. (26), reproduced with permission.
Table I. Description of study participants
Exposure condition Total 
subjects
No. 
families
No. individuals (age range)
Adult 
females
Adult 
males
Childern 
(≤15 years)
Unexposed (control) 9 3 3 1 5
Exposed 32 17 11 9 12
Total 41 20 14 (16–53) 10 (18–69) 17 (2–15)
368
Human urinary mutagenicity after wood smoke exposure
strain TA98, and Aroclor-induced S9 yielded the highest response for urine 
extracts from wood smoke-exposed individuals. An initial range-finding 
test showed that some of the post-exposure extracts were cytotoxic at 12-ml 
equivalents per plate (data not shown); therefore, the concentrations selected 
for mutagenicity testing were 0.3, 0.6, 1.2, 3.0 and 6.0 ml-equivalent urine 
per plate. All concentrations were tested in duplicate. A simultaneous positive 
control (i.e. 0.1 µg/plate 2-aminoanthracene, Molecular Toxicology Inc.) and 
negative solvent control (i.e. DMSO) were used on each day of mutagenic-
ity testing. Following a 72-h incubation at 37°C, the frequency of mutant (i.e. 
revertant; rev) colonies was scored using a ProtoCol automated colony coun-
ter (Synbiosis Corporation, Exton, PA, USA). Mean positive control values 
were 1857.4 ± 104.7 rev/plate, and mean negative control values were 58.5 ± 3.2 
rev/plate. Mutagenic potency was calculated as the slope of the linear portion 
of the concentration-response function as described below, and expressed as 
revertants/ml-equivalent urine.
Urine samples were adjusted for creatinine concentration in order to reduce 
the effects of interindividual variability in glomerular filtration rate (i.e. urine 
dilution). Urinary creatinine analysis was conducted using a colorimetric assay 
(Oxford Biomedical, Abingdon, UK) and levels employed to correct for uri-
nary flow rate. Mutagenic potency values corrected for creatinine concentra-
tion were expressed as revertants/µmole urinary creatinine. When comparing 
creatinine-adjusted urinary mutagenic potency with other metrics (e.g. time in 
temazcal), particular attention was paid to the age of the subjects (e.g. adults 
versus children), since urinary creatinine levels have been shown to be depend-
ent on both body mass and age. Consequently, comparisons of creatinine-
adjusted values between adults and children must be interpreted with caution 
(30,31). Individual subject mutagenic potency values are available from the 
first author upon request.
Statistical analyses
Statistical analyses employed SAS v9.2 for Windows (SAS Institute, Cary, NC, 
USA) and Microsoft Excel. Mutagenic potency values were determined using 
ordinary least squares linear regression analysis. A paired (dependent) t-test 
was used to evaluate the treatment effect (i.e. pre- versus post-exposure) for 
unadjusted urinary mutagenic potency, creatinine-adjusted urinary mutagenic 
potency as well as exhaled CO (i.e. H0 that the mean difference between pre- 
and post-exposure is zero). The test assumes that the dependant variable (e.g. 
mutagenic potency) is continuous, that the subjects are matched, and the dif-
ferences between the pre- and post-exposure measurements are independent 
and normally distributed. Normality of the difference values was confirmed 
using the Shapiro–Wilk test, the Kolmogorov–Smirnov test and visual inspec-
tion of a normal probability plot. Single-factor analysis of variance (ANOVA) 
was also employed to examine differences between the exposure groups (i.e. 
pre-exposure and post-exposure) and the control group for unadjusted urinary 
mutagenic potency, creatinine-adjusted urinary mutagenic potency and exhaled 
CO. Least squares linear regression was also employed to investigate empirical 
relationships between mutagenic potency and other variables that reflect the 
magnitude of the exposure (e.g. exhaled CO level, time spent in temazcal), 
as well as between exhaled CO level and time spent in temazcal. Analysis of 
the studentised deleted residuals (32) was employed to detect outliers from 
the empirical relationships between urinary mutagenicity and exposure time, 
and between urinary mutagenicity and exhaled CO. Empirical relationships 
between the various variables investigated (e.g. creatinine-adjusted urinary 
mutagenic potency, subject age, time spent in temazcal and exhaled CO) were 
investigated using ordinary least squared linear regression and analysis of 
covariance (ANCOVA). The analysis assumes that disturbance term µi (also 
known as the residuals) are independent and normally distributed with mean of 
zero and constant variance of σ2. The assumption of independence is easily met 
since each observation represents a different subject. The assumption of nor-
mality was examined using the Shapiro–Wilk test, the Kolmogorov–Smirnov 
test and visual inspection of a normal probability plot.
Results
Urinary mutagenic potency
All control and post-exposure urine extracts induced a 
concentration-dependent mutagenicity response in Salmonella 
YG1041, as did all but three of the pre-exposure extracts. 
Substantial cytotoxicity was observed in some samples at 3- and 
6-ml equivalent concentrations, several samples also exhibited 
toxicity at 1.2-ml equivalent urine, and a few samples exhibited 
toxicity at 0.6-ml equivalent urine. One sample elicited 
toxicity at all concentrations above 0.3-ml equivalent urine. 
Consequently, a mutagenic potency could not be calculated for 
this sample and it was excluded from further analyses. Crude 
mutagenic potencies ranged from 0 (i.e. no significant response 
compared with solvent control) to 120 rev/ml-equivalent urine. 
Adjustment of urinary mutagenicity for variations in creatinine 
concentration permits control for variations in glomerular 
filtration rate across subjects and reduces interperson variability 
(31,33,34). Creatinine data were not available for two post-
exposure samples, and therefore creatinine-adjusted mutagenic 
potencies could not be calculated for these samples. Creatinine-
adjusted mutagenic potencies calculated for all samples ranged 
from 0 to 3.06 rev/µmol urinary creatinine.
A paired t-test was conducted on creatinine-adjusted muta-
genic potencies to compare pre- and post-exposure urinary 
mutagenicity in the same individual. This type of analysis 
requires a pre- and post-exposure value for each individual, 
and, as a result, one individual was removed from the analy-
sis since the post-exposure mutagenic potency could not be 
calculated due to toxicity. Two additional individuals were 
removed from the analysis since there was no creatinine infor-
mation for the post-exposure samples (see above). The results 
revealed a significant 1.74-fold increase (P < 0.005) between 
the urinary mutagenicity of the pre- and post-exposure sam-
ples (Figure  2A). Crude (i.e. unadjusted) urinary mutagenic 
potencies were also analysed in this manner, and the results 
also revealed a significant difference between the pre-exposure 
and post-exposure samples (1.66-fold post-exposure increase, 
P  <  0.007). As noted, one individual was removed from the 
analysis because of sample toxicity. Scrutiny of the distribution 
of the difference values (i.e. between pre- and post-exposure) 
did not reveal any significant deviations from normality (i.e. 
P > 0.1). Nevertheless, for completeness, the data were also 
analysed using the non-parametric paired sample Wilcoxon-
signed rank test. The results revealed a significant treatment 
effects for both the unadjusted (crude) mutagenic potency val-
ues (P < 0.005) as well as the creatinine-adjusted potency val-
ues (P < 0.003). All additional analyses were only conducted 
on creatinine-adjusted values.
In order to compare the exposure groups with the control 
group, one-way ANOVA was conducted on creatinine-adjusted 
data (i.e. pre-exposure versus control and post-exposure versus 
control). This analysis revealed a significant difference (P < 0.05) 
between the control and post-exposure group (Table  II). The 
mean urinary mutagenic potency for the post-exposure group 
was, on average, 1.7-fold greater than the control (unexposed) 
group (Table II). There was no statistically significant difference 
between the mutagenic potency of the unexposed controls and 
the pre-exposure samples (Table II). In addition, there was no 
significant difference between the post-exposure urinary muta-
genic potency of adults versus children (Table III).
Duration of temazcal exposure
The self-reported duration of temazcal use varied quite widely 
from only 11 min (child) to 98 min (adult; Table III). The 
mean duration time for temazcal use across all subjects was 
37 ± 4 min, with the adults using the temazcal for almost 50% 
longer than the children (1.4-fold; Table III).
Exhaled CO levels
Pre- and post-exposure CO measurements were available 
for 19 individuals and these data were also analysed using a 
paired t-test. The results indicate that the use of temazcales is 
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associated with significant modification of exhaled CO level. 
More specifically, there was a statistically significant increase 
in exhaled CO (ppm) following temazcal use relative to pre-
exposure measurement (P < 0.0001; Figure 2B).
Pre-exposure exhaled CO values ranged from 1.5 ppm to 8.0 
ppm (mean = 4.3 ppm), and post-exposure values ranged from 
17.7 ppm to 166.0 ppm (mean = 55.9 ppm; Table II). One-way 
ANOVAs were conducted in order to compare the exposure 
measurements (i.e. pre- and post-exposure) with the control 
group; however, there was no significant difference in either 
case. The lack of significant difference between the control 
and post-exposure group is likely a consequence of the limited 
control data and lack of statistical power (i.e. only two control 
individuals with CO measurements, P = 0.065). Nevertheless, 
the mean exhaled CO for the post-exposure group was 11.8-
fold greater than the mean control, whereas the pre-exposure 
A
B
Fig. 2. (A) The distribution of creatinine-adjusted urinary mutagenic potency values for individuals examined the morning prior to temazcal use (i.e. pre-
exposure) and the morning following temazcal use (i.e. post-exposure). Matched pre- and post-exposure data were available for 29 individuals. Post-exposure data 
were not available for individuals #431 and #512 (lack of creatinine data), as well as #1010 (toxicity). The box represents the interquartile range, the dashed lines 
denote mean values, the solid lines denote medians and the whiskers denote the 10th and 90th percentiles. (B) The distribution of exhaled CO concentration for 
individuals examined immediately prior to temazcal use (i.e. pre-exposure) and immediately following temazcal use (i.e. post-exposure). Matched pre- and post-
exposure data were available for 19 individuals. There were data missing for either the pre- or post-exposure CO measurements (or both) for the following subject 
IDs: 113, 220, 222, 223, 312, 321, 431, 713, 1025, 430, 814 and 960. The box represents the interquartile range, the dashed lines denote mean values, the solid 
lines denote medians and the whiskers denote the 10th and 90th percentiles.
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group had roughly the same exhaled CO as the control group 
(Table II). Exhaled CO levels following temazcal use (i.e. post-
exposure) were not significantly different between adults and 
children (Table III).
Relationships between exposure metrics
Analysis of the studentised deleted residuals from the mutagenic 
potency versus CO relationship revealed statistically significant 
outliers at P < 0.05, and these observations were removed from 
subsequent analyses (i.e. both the pre- and post- observations 
for individual #812, the pre-observation for #911, and the post-
observation for #611). Urinary mutagenic potency was found to 
be empirically related to CO level (P < 0.0001, r2 = 0.53), with 
increased CO associated with increases in urinary mutagenicity 
(Figure  3). This relationship was improved when only the 
data from the adults were included (P  <  0.0001, r2  =  0.57; 
supplementary Figure  1, available at Mutagenesis Online). 
Additionally, post-exposure urinary mutagenicity was found 
to be positively associated with the amount of time that each 
individual spent in the temazcal (P = 0.01, r2 = 0.19; Figure 4), 
and again the relationship was improved when only the data from 
the adults were included (P < 0.005, r2 = 0.44; supplementary 
Figure 2, available at Mutagenesis Online). Exhaled CO levels 
were also found to be positively associated with exposure 
duration (i.e. time spent in the temazcal; P < 0.005, r2 = 0.57; 
Figure 5), and this relationship was also improved when only 
adult data were included (P < 0.0005, r2 = 0.82; supplementary 
Figure 3, available at Mutagenesis Online).
ANCOVA examining the effects of both subject classifi-
cation (i.e. adults versus children ≤15 years old) and time in 
temazcal revealed significant effects of both subject classi-
fication and time, with homogeneous slopes (i.e. no interac-
tion between subject classification and time in temazcal). The 
results revealed a significant model with r2 = 0.36 (N = 30) and 
F ratio  =  7.67 (P  <  0.005). The subject classification effect 
was significant at P < 0.05 (F = 7.14) with adult creatinine-
adjusted mutagenic potency values, on average, 0.4 units lower 
than children. The time effect was significant at P  <  0.005 
(F  =  12.2) with coefficient (i.e. slope)  =  0.010 ± 0.003. This 
coefficient is not significantly different from the slopes of the 
relationships shown in Figure 4 and supplementary Figure 2, 
available at Mutagenesis Online. Scrutiny of the distribution 
of the residuals for each of the aforementioned regression or 
ANCOVA models did not reveal any serious deviations from 
normality. Nevertheless, for the regression of post-exposure 
creatinine-adjusted mutagenic potency versus time, analysis of 
the residuals revealed the H0 of normality could be rejected at 
P  =  0.06. Additional analyses using log10 transformed muta-
genic potency revealed similar results (i.e. time effect with 
P<0.02) and residuals that showed no evidence of deviation 
from normality (Shapiro–Wilk P = 0.55).
Discussion
This study examined urinary mutagenicity in individuals 
exposed to wood combustion emissions during the use of 
traditional temazcales; moreover, empirical relationships 
between urinary mutagenic activity and other measures of 
wood smoke exposure (e.g. exhaled CO and time spent in the 
temazcal).
Table II. Summary of creatinine-adjusted urinary mutagenic potency and exhaled CO levels for unexposed and exposed subjects (both pre- and post-exposure)
Exposure condition Urinary mutagenic potency (revertants/µmol creatinine) Exhaled carbon moxidea (ppm)
N Range Mean (±SE) Fold change  
(wrt child)
P-value N Range Mean (±SE) Fold change  
(wrt child)
P-value
Unexposed (control) 9 0.17–1.13 0.51 (0.11) – – 2 4.0–5.5 4.8 (0.8) – –
Pre-exposure 32 0–1.53 0.49 (0.07) 1.0 NS 23 1.5–8.0 4.3 (0.3) 0.9 NS
Post-exposure 29b 0.22–1.81 0.84 (0.08) 1.7 <0.05 20 17.7–166.0 55.9 (8.1) 11.8 NS
SE, standard error; NS, not significant; wrt, with respect to. A one-way ANOVA was employed to compare the pre-exposure and post-exposure groups with 
control individuals.
aCarbon monoxide data were not available for all individuals.
bThree samples were removed from this group. Subject ID #431 (M) and 512 (F) lacked creatinine data. Subject ID #1010 (F) was removed due to toxicity.
Table III. Summary of exposure duration, post-exposure exhaled CO levels and post-exposure creatinine-adjusted urinary mutagenic potency for adults and 
children
Study subject Duration of exposurea (min) Exhaled carbon monoxideb  
(post-exposure; ppm)
Urinary mutagenic potencyc (post-
exposure; rev/µmol creatinine)
N Mean 
(±SE)
Range Fold change 
(wrt child)
N Mean (±SE) Range Fold change 
(wrt child)
N Mean (±SE) Range Fold change 
(wrt child)
Age group Child (≤15 years) 8 29.5 (2.8) 17.0–37.0 – 6 61.1 (14.1) 30.0–111.0 – 12 0.92 (0.15) 0.33–1.81 –
Adult 15 40.6 (6.5) 11.0–98.0 1.4 14 53.6 (10.1) 17.7–166.0 0.9 17 0.79 (0.10) 0.22–1.52 0.9
SE, standard error; NS, not significant; wrt, with respect to. Exposure duration and exhaled CO data were not collected for all study subjects, and analyses were 
conducted using all available data. Creatinine values were missing for two individuals in the post-exposure group, and one post-exposure urinary mutagenic 
potency value was excluded due to toxicity.
aExposure duration data were not available for four children (Subject ID #s 712, 713, 1012 and 1025), three adult females (#s 710, 920 and 1010) and two adult 
males (#s 721 and 911).
bCO data were not available for all individuals.
cThree post-exposure urinary mutagenic potency data were not available. Subject ID #431 (M) & 512 (F) lacked creatinine data. Subject ID #1010 (F) was 
removed due to toxicity.
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Urinary mutagenic potency
All urine extracts, with the exception of three pre-exposure 
samples, induced a significant mutagenic response in 
Salmonella strain YG1041 with S9 metabolic activation, and 
this is consistent with the aforementioned study by Kato et al. 
(21). YG1041, which overexpresses the Salmonella classical 
nitroreductase and O-acteytltransferase, is known to display 
increased sensitivity to nitroarenes and aromatic amines 
(35). Therefore, since extracts of urine from wood smoke 
exposed individuals have been previously shown to elicit a 
stronger response on YG1041, relative to its parent strain 
TA98, it seems likely that the extracts of deconjugated urinary 
metabolites contain aromatic amines as well as metabolites 
of homocyclic, unsubstituted PAHs. Indeed, studies have 
shown that the urine of individuals exposed to PAH-containing 
combustion emissions (i.e. wood smoke and cigarette smoke) 
contain metabolites of aromatic amines such as o- and 
p-toluidine, and 2-aminonapthalene, as well as metabolites of 
unsubstituted PAHs including 2-napthol and 1-hydroxypyrene 
(20,21,24,36,37). Furthermore, enhanced responses in the 
presence of S9 in this and other studies (20,21,23,24) are 
consistent with the excretion of PAHs and PAH metabolites 
that require metabolic activation to elicit a positive response in 
the Ames/Salmonella reverse mutation assay (38).
Toxicity was observed in some samples at concentrations of 
6.0- and 12.0-ml equivalents of urine (per plate) and for one 
sample at a concentration of 3.0-ml equivalent urine. This latter 
sample was a post-exposure sample from an adult female with 
an exhaled CO value of 60 ppm, which is the highest exhaled 
CO value recorded for post-exposure adult women in this 
Fig. 4. The relationship between urinary mutagenicity, expressed as creatinine-adjusted potency and time spent in temazcal (i.e. exposure duration) for control 
and post-exposure samples. Thirty individuals had both creatinine-adjusted mutagenic potency and exposure duration data. Coefficient (i.e. slope) of the time 
effect = 0.0082 ± 0.0032. M = adult male, F = adult female, C = child. RMS = root mean square error.
Fig. 3. The relationship between urinary mutagenicity, expressed as creatinine-adjusted potency, and exhaled CO concentration for control, pre-exposure and 
post-exposure samples. Thirty-nine observations had both creatinine-adjusted mutagenic potency and exhaled CO data. Four observations were determined to 
be statistical outliers and excluded from the analysis (i.e. both the pre- and post- observations for individual #812, the pre- observation for #911 and the post-
observation for #611). Coefficient (i.e. slope) of the CO effect = 0.0071 ± 0.0011. M = adult male, F = adult female, C = child. RMS = root mean square error.
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study. Toxicity of urine extracts was also observed in the Kato 
et al. (21) study of wood smoke exposed charcoal production 
workers, and the observation of cytotoxicity is consistent with 
studies that have noted the acute cytotoxicity of wood smoke 
condensates (39). Toxicity may also be unrelated to wood 
smoke exposure.
The range of urinary mutagenicity values in the current study 
was low relative to values presented in the Kato et  al. (21) 
study. The mean mutagenic potency value recorded for adults 
in the current study (i.e. 0.79 rev/µmol creatinine) is ~5.5-fold 
lower than the mean value for the high exposure group (i.e. 4.5 
rev/µmol creatinine), and ~3-fold lower than the mean value 
for the low exposure group in the Kato et al. study (21). This 
difference may not be surprising since the individuals in the 
Kato et al. (21) study were chronically exposed to wood smoke 
in an occupational setting, and the samples were collected after 
3 days of exposure (i.e. third day of the work week). In contrast, 
the current study examined individuals exposed to high levels 
of wood smoke for brief periods of time (i.e. mean exposure 
time of 37 min) with urine samples collected the morning fol-
lowing the exposure. Additionally, the individuals in the Kato 
et  al. (21) study were exposed during occupational activities 
that would be expected to increase respiration rate and expo-
sure level, in comparison with the individuals in our study who 
were exposed while seated in the temazcal.
There were only two studies that examined urinary muta-
genicity in smokers using the same strain of bacteria (i.e. 
YG1041), and in both cases the mean value obtained following 
wood smoke exposure in our study was much lower than those 
obtained for the smokers. The Kato et al. (21) study examined 
urinary mutagenicity in smokers who worked at the charcoal 
plant and reported a mean of 4.23 rev/µmol creatinine. A sec-
ond study examined urinary mutagenicity in smokers who 
worked in the rubber manufacturing industry and reported a 
mean of 4.43 rev/µmol creatinine (i.e. 39 148 rev/g creatinine) 
(40). However, both of these studies examined urinary muta-
genicity in smokers who were also occupationally exposed, and 
therefore it is difficult to compare the levels of urinary muta-
genicity in our study, to those that would be obtained strictly 
from smoking.
The absence of a significant difference between the urinary 
mutagenicity of the unexposed control samples and the pre-
exposure samples suggests that the time interval between suc-
cessive temazcal exposures (usually one week) was sufficient 
to permit the levels of urinary mutagenicity to return to back-
ground. However, since temazcal use is not consistent among 
all study participants (26) and can vary from 1 to 3 times per 
week, it was not possible to precisely determine the elapsed 
time between each exposure. Nevertheless, we contend that 
the effect of temazcal use, and the effect of the ensuing wood 
smoke exposure on urinary mutagenicity, is not persistent, and 
without consecutive daily exposures the urinary mutagenic-
ity levels return to background. This contention is consistent 
with experimental observations of PAH excretion kinetics. For 
example, a study of F-344 rats orally exposed to BaP noted 
that maximum recovery of BaP metabolites in urine occurred 
within 48 h after administration (41), and 15–25% of metabo-
lites were recovered between 8 and 16 h following administra-
tion (41). In addition, studies of Sprague–Dawley rats exposed 
to pyrene demonstrated that 60% of the original pyrene dose 
was recovered in urine 24 h after the last dose, and about 35% 
of the dose was recovered at 10 h post-exposure (42). The lat-
ter study also examined the influence of mixtures of PAHs (i.e. 
BaP, naphthalene and pyrene) on the excretion of pyrene and 
found that simple PAH mixtures did not influence excretion 
kinetics (42). More complex PAH mixtures, such as those that 
would be present in an environmental or occupational setting 
(e.g., wood smoke), were not examined. Importantly, another 
study found that the fraction of the original dose recovered in 
urine as 1-hydroxypyrene (mainly as sulpho-conjugates) was 
not affected by exposure route or dose and that there was a 
linear dose-excretion relationship (43) Thus, although avail-
able toxicokinetic information confirms that the urine extracts 
examined in this study would be expected to contain a diverse 
array of deconjugated metabolites from the investigated expo-
sure, the toxicokinetics of combustion by-products such as pyr-
ene suggest that the delay between the acute (i.e. single brief 
event) wood smoke exposure and the urine collection employed 
here may not have been optimal for detection of the peak in 
urinary mutagenicity. Future studies should ideally examine the 
Fig. 5. The relationship between exhaled CO, expressed as ppm and time spent in temazcal (i.e. exposure duration) for control and post-exposure samples. 
Fifteen individuals had both exhaled CO and exposure duration data. Coefficient (i.e. slope) of the time effect = 1.45 ± 0.35. M = adult male, F = adult female, 
C = child. RMS = root mean square error.
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kinetics of urinary mutagen excretion following discrete temaz-
cal exposures.
In this study, we were able to detect a significant difference 
in urinary mutagenicity levels between pre- and post-exposure 
samples, as well as between the control group and post-expo-
sure samples, without controlling for other sources of com-
bustion exposures (i.e. wood stoves). Many of the subjects in 
this study would use wood stoves at home for cooking, and 
this would be expected to contribute to the total wood smoke 
exposure (44). Thus, the results obtained here indicate that 
urinary mutagenicity is a sensitive biomarker of single acute 
exposure events, and the exposure metrics appears to be suffi-
ciently robust such that a correction for confounding exposures 
was not required to reveal a statistically significant relation-
ship between exposure status/duration and urinary mutagenic 
activity. Nevertheless, control for confounding exposures 
would most likely strengthen the empirical relationships inves-
tigated (e.g. Figure  4, supplementary Figure  2, available at 
Mutagenesis Online).
Previous studies examining urinary mutagenicity have 
largely compared groups of individuals who were categorised 
into exposure groups based on their lifestyle (e.g. smoking sta-
tus and area of residence) or occupational settings (21–24,45–
48). Industrial exposures were examined by comparing work 
week urine samples with weekend/home urine samples (49–52) 
or simply by comparing individuals from the control popula-
tions to individuals from the exposed populations (20,53–56). 
In our study, we examined the same individuals before and 
after a single brief exposure event. This type of paired exposure 
design is advantageous since it is not prone to variations in the 
exposure metric attributable to interindividual variability. Only 
four other studies employed this type of study design to suc-
cessfully detect an increase in urinary mutagenicity following 
a single exposure event, with one examining the effects of fried 
pork ingestion (57), one study looking at non-smoker’s urinary 
mutagenicity after smoking cigarettes (58) and two studies 
examining the effects of passive smoking on urinary mutagen-
icity (59,60). To our knowledge, this study constitutes the first 
use of a paired exposure design to show a significant increase 
in urinary mutagenicity following a single brief exposure to a 
wood smoke-contaminated aerosol.
Relationships between exposure metrics
Levels of urinary mutagenicity in individuals who used 
traditional temazcales was found to be significantly related to 
both the duration of wood smoke exposure (i.e. time spent in 
temazcal) and the exhaled CO measured following temazcal 
use. The fact that the post-exposure urinary mutagenic 
potency was significantly correlated with the time spent 
in the temazcal demonstrates that urinary mutagenicity is 
significantly augmented by the exposure that occurs during 
the use of traditional temazcales. Although the level of urinary 
mutagenicity is clearly influenced by other, hitherto unidentified 
factors, the observed empirical relationship permits the 
contention that urinary mutagenicity is a useful biomarker of 
exposure to combustion emissions associated with the use of 
traditional temazcales, particularly for adults.
Levels of urinary mutagenicity were also found to be signifi-
cantly associated with exhaled CO levels (i.e. r2 = 0.53 for all 
individuals, and r2 = 0.57 for adults only; Figure 3, supplemen-
tary Figure 1, available at Mutagenesis Online). CO has been 
previously used as a biomarker of wood smoke exposure since 
it is known to be directly associated with inhalation of wood 
smoke (13,61–67). In our study, exhaled CO levels were also 
shown to be significantly associated with the exposure duration 
(Figure  5, supplementary Figure  3, available at Mutagenesis 
Online). However, CO levels do not provide an indication of 
the magnitude of the exposure to mutagenic and/or carcino-
genic compounds that are known to be present in wood smoke 
and, moreover, known to augment the risk of tumour formation. 
Significant association of urinary mutagenicity with exhaled 
CO increases confidence in the use of urinary mutagenicity as 
an effective biomarker of wood smoke exposure; moreover, as 
a biomarker that may be used to indicate an increased risk of 
adverse health effects associated with exposures to environ-
mental mutagens.
Although the paired exposure design controls for interin-
dividual variability that could be attributed to susceptibility 
factors (i.e. genetic polymorphisms), it cannot account for con-
founding exposures that take place before or after temazcal use, 
nor when comparing post-exposure values to other exposure 
metrics. Genetic polymorphisms relating to the metabolism 
of combustion by-products could potentially be a factor in the 
individuals identified as statistical outliers. The Kato et al. (21) 
study noted that the urinary excretion of 2-naphthol and 1-pyr-
enol, PAH metabolites that have been employed as biomarkers 
of wood smoke exposure, was significantly elevated in wood 
smoke exposed individuals with the GSTM1 null genotype. It 
was also previously determined that in Polish children living 
in a region with high levels of and environmentally polluted 
air, polymorphisms in EPHX1 significantly affected both the 
1-OHP concentration in urine, as well as urinary mutagenic-
ity (68). Additionally, they determined that the GSTM1 null 
genotype or the deletion of GSTT1 both resulted in signifi-
cantly increased levels of PAH-DNA adducts in the carriers. 
The authors also found that higher levels of PAH-DNA adducts 
were associated with individuals with the Lys/Lys genotype of 
the DNA repair gene XPD, in comparison with heterozygotes 
for this gene (68). Confounding exposures (e.g. wood stove 
use) were not controlled in this study; however, it should be 
noted that nearly all individuals in the examined population 
would be expected to experience additional wood smoke expo-
sures in and around the home.
Children versus adults
In the population examined, it is common for an adult to enter 
the temazcal first to prepare the fire. The rest of the family 
enters afterwards, and, as a result, the children generally spend 
less time in the temazcal relative to adults. In our study, we 
noted that adults spent almost 50% more time in the temazcales 
in comparison with children (Table III); however, post-
exposure levels of exhaled CO and the post-exposure urinary 
mutagenicity levels in adults were approximately the same as 
those of children (Table III). Moreover, the ANCOVA analysis 
revealed that for a given time in the temazcal, the creatinine-
adjusted urinary mutagenic potency for children was on average 
0.4 units greater than those of adults (P < 0.05). These results 
suggest that children may be more sensitive to wood smoke 
exposure, at least in terms of exhaled CO and urinary mutagenic 
activity. This contention is consistent with information in 
the literature pertaining to differences in the susceptibility of 
children and adults to the effects of environmental pollutants. 
More specifically, differences that can be attributed to well-
known physiological differences that relate to body size, 
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metabolic rate, organ size and metabolic capacity. For example, 
children can be exposed to disproportionately higher levels of 
environmental contaminants in aerosols, relative to adults, due 
to an elevated respiration rate (69–71); moreover, children have 
a larger liver (expressed per unit body weight) in comparison 
with adults (70). In the context of this study, an increased 
respiration rate would be expected to contribute to an elevated 
wood smoke exposure for a given exposure duration, relative 
to adults, and an increased liver size would be expected to 
permit increased metabolism and urinary excretion of wood 
smoke combustion by-products. Additionally, it is interesting 
to note that from the age of 6 months to 12 years, children are 
significantly more effective at clearing CYP1A2 substrates 
(72). Approximately 15% of the P450 content in human liver 
is CYP1A2, which is essential for the conversion of aromatic 
amines to hydroxyarylamines (73–75). This may result in a 
higher rate of metabolism and urinary excretion of selected 
combustion by-products, which is consistent with the observed 
increase, relative to adults, in urinary mutagenic potency 
observed for a given exposure time. The aforementioned results 
are also in agreement with those presented in Lam et al. (27), 
where it was noted that although children used the temazcal 
for half as long as adults, there was no significant difference in 
post-exposure exhaled CO level.
As mentioned above, the urinary creatinine correction may not 
be as appropriate for children as it is for adults and, moreover, 
for comparing results across age groups. Removing the chil-
dren’s data from the correlation analyses resulted in improved 
coefficients of correlation for the creatinine-adjusted urinary 
mutagenic potency versus exhaled CO, and creatinine-adjusted 
urinary mutagenic potency versus time in temazcal (supple-
mentary Figures 1 and 2, available at Mutagenesis Online). The 
data points for children show considerable scatter for the plot 
of creatinine-adjusted mutagenic potency versus time (Figure 4), 
even at zero time. It is well known that children excrete lower 
levels of creatinine than adults as a result of their lower lean mus-
cle mass. In a large-scale study that analysed National Health 
and Nutrition Examination Survey data, the authors reported 
that children between the ages of 6–11 had urinary creatinine 
concentrations that were only 60% of those for ages 20–29 
(i.e. 102.1 mg/dl versus 161.8 mg/dl) (31). Following creati-
nine adjustment, lower urinary creatinine concentrations in 
children would result in relatively higher creatinine-adjusted 
urinary mutagenic potency values, compared with adults. This 
may explain some of the scatter observed for the children’s data 
points in Figure 4, as there are a number of data points that fall 
above the regressed line. Additionally, the aforementioned physi-
ological differences between adults and children may be contrib-
uting to the considerable scatter observed for the children’s data 
points. The children in our study range from 2–15 years of age. 
Not only do children vary in a number of physiological capaci-
ties from adults, but there is also considerable variability in these 
physiological parameters between different age groups of chil-
dren as they develop. For example, for drug clearance data, chil-
dren who are between the ages of 12–18 years do not statistically 
differ from adults; however, children from 2–12 years have sig-
nificantly higher clearance rates than adults (72). Additionally, 
young children have a proportionally larger liver weigh-to-body 
weight ratio (in comparison with adults), but this discrepancy 
levels off after once the child reaches 6 years of age (70). The 
removal of the children’s data from the correlation of exhaled CO 
versus time in temazcal also resulted in an improved correlation 
coefficient. This may be a result of the physiological differences 
between adults and children, as discussed above. Finally, there 
were only 12 children in the exposure group (only eight with CO 
values) and five children in the control group (1 with CO values), 
so the small sample size may also be contributing to the scat-
ter and is a limitation of this study. Future research with larger 
groups of children is required to better understand the effects of 
wood smoke exposure in children.
Conclusions
The results of this study demonstrate that urinary mutagenicity 
is a reliable and sensitive biomarker for assessment of single, 
acute exposures to wood smoke-derived combustion emissions 
in an enclosed space. Moreover, the metric can be readily 
employed in the absence of a priori information regarding 
chemical identity of the putative mutagens in the combustion 
emission (i.e. wood smoke). This study constitutes the first 
demonstration of the genotoxic hazards associated with 
temazcal use, and the first demonstration of a significant 
increase in urinary mutagenicity following a single acute wood 
smoke-contaminated aerosol exposure event.
Combustion emissions, including wood smoke, are known 
to be mutagenic in animals and humans (1), and an increase 
in urinary mutagenicity has previously been shown to be 
associated with genetic damage, such as DNA adducts in 
urothelial cells (28). Temazcal use may therefore result in an 
increased likelihood of genetic damage and mutations, which 
have been associated with initiation of tumour formation and 
carcinogenesis.
Due to poverty and the cultural significance of the temazcal, 
it may be difficult to immediately reduce wood smoke expo-
sures associated with temazcal use. Working with this popula-
tion to increase ventilation in the temazcales, heat the rocks 
outside the structure (as is common in other Native American 
populations) or remove the embers before entering, as well as 
reducing exposure time, would reduce the likelihood of harm-
ful effects, particularly in children.
Supplementary data
Supplementary Figures 1–3 are available at Mutagenesis 
Online.
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